Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (127)	8/10/1999 12:36:00 PM
From: scaram(o)uche	Read Replies (2) of 427

Biowa: Your point is well taken. However, one needs to study the various paths to converts. Some damn good companies have fallen on hard times after their product candidates have failed in trials. Timing stunk, such that the failure compounded a lack of cash at a time where funding was tough. Hard to blame that (those) CEO(s). Berger, OTOH, made no attempt to garner money for shares when at $7. He is also known for having asked for too much from potential partners. Lots of guts and science, short on common sense. That said, I hope that Berger can recover. He doesn't seem the sort that is permanently afflicted. I'll therefore stop short of tar and feather. For now. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next